× Elizabeth Holmes Returns to the Stand on Tuesday.
Doctor, research and entrepreneur Elizabeth Holmes, the founder of the pharmaceutical technology company Theranos, will return to the Stand for Children’s debate this month after she was asked to withdraw in 2017 after learning of “irregularities” in its blood-testing procedures.
Holmes will be returning to the Las Vegas debate on March 13 to appear alongside 11 other activists and leaders at the annual Nelson Mandela Children’s Fund conference.
A jury of 60 respected experts in medicine, business, science and media agreed on Friday to endorse a decision in December by the AHA to invite Holmes to participate in the upcoming march, CNN’s Kyoungdo Kim reported.
Five scientists who oversaw testing that Holmes missed as she sat on the sidelines were unable to attend and recommended that she reconsider her return to the conference, Kim reported.
As she was leaving the stage at the AHA Leadership Forum in 2014, Holmes replied to a report: “Unbelievable! Every bullet in every box is bulletproof.”
Holmes publicly apologized to the AHA leadership forum in a July 2017 statement and announced plans to pay $5 million to the charity and change its leadership.
Dr. Fred Kramer, a former scientist at Theranos who brought the company’s science to the AHA, presented the AHA’s scientists with the breach of scientific integrity allegation, which was based on a single observation of a blood test result.
“I believe in ‘No Fault’ testing, and yet I see things that warrant the kinds of full investigations we so strongly support,” Kramer wrote in an email. “Elizabeth Holmes and Theranos have refused to acknowledge any scientific and business integrity issues.”
After correcting the evidence, Kramer added, “The people who have the strongest desire to discredit the independent science should never be part of it.”
Theranos was allegedly deceived about its technology, excluded its results from peer review, violated AHA guidelines and administered “excessive” testing with multiple machines.
In 2016, Theranos agreed to pay $200 million in settlements with federal and state regulators and withheld data about its results.
Holmes was not found guilty of fraud.